ACP
JNCE

Acuta Capital Partners’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Acuta Capital Partners’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-813,500
Closed -$5.52M – 51
2022
Q1 		$5.52M Buy
813,500
+686,000
+538% +$4.66M 2.58% 14
2021
Q4 		$1.07M Buy
+127,500
New +$1.07M 0.45% 35